IMMUCELL CORP /DE/ — Director's Dealing 2017

Mar 15, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2017-03-13

Reporting Person: Tomsche David Scott (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-13	Common Stock, par value $0.10 per share	P	490.0000	$5.4000	Acquired	71279.0000	Direct
2017-03-13	Common Stock, par value $0.10 per share	P	313.0000	$5.4500	Acquired	71592.0000	Direct
2017-03-14	Common Stock, par value $0.10 per share	P	150.0000	$5.4600	Acquired	71742.0000	Direct
2017-03-14	Common Stock, par value $0.10 per share	P	658.0000	$5.4500	Acquired	72400.0000	Direct
2017-03-14	Common Stock, par value $0.10 per share	P	389.0000	$5.4100	Acquired	72789.0000	Direct

Footnotes

F1: (1) This figure includes 2,322 shares of common stock held by immediate family members of Dr. Tomsche.